NCT03495921 2023-04-26
VITA
Gradalis, Inc.
Phase 3 Terminated
Gradalis, Inc.
Provectus Pharmaceuticals
Tufts Medical Center
National Cancer Institute (NCI)
Sun Yat-sen University
European Organisation for Research and Treatment of Cancer - EORTC
Bradmer Pharmaceuticals Inc.